# A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

> **NCT03516331** · PHASE1 · COMPLETED · sponsor: **Flatley Discovery Lab LLC** · enrollment: 16 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** FDL176 & FDL169 coadministration

## Key facts

- **NCT ID:** NCT03516331
- **Lead sponsor:** Flatley Discovery Lab LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2018-08-22
- **Final completion:** 2018-08-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03516331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03516331, "A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03516331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*